Bart De Geest

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Topics

Low Density Lipoprotein

Oxidative Stress

Top Venues

International journal of molecular sciences

European heart journal

This page only lists publications with an associated author ORCID identifier.

Publications

Bart De Geest, Sophie Van Linthout
Non-HDL-cholesterol reduction: the challenges of applying clinical trial results in the real world. European heart journal (2024)
Luxi Ji, Mudit Mishra, Bart De Geest
The Role of Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure Management: The Continuing Challenge of Clinical Outcome Endpoints in Heart Failure Trials. Pharmaceutics 15 (4) (2023)
Luxi Ji, Mudit Mishra, Bart De Geest
The Role of Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure Management: The Continuing Challenge of Clinical Outcome Endpoints in Heart Failure Trials. Pharmaceutics 15 (4) (2023)
Bart De Geest, Mudit Mishra
The metabolic syndrome in obese and non-obese subjects: a reappraisal of the syndrome X of Reaven. European journal of preventive cardiology (2023)
Luxi Ji, Mudit Mishra, Bart De Geest
The Role of Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure Management: The Continuing Challenge of Clinical Outcome Endpoints in Heart Failure Trials. Pharmaceutics 15 (4) (2023)
Luxi Ji, Mudit Mishra, Bart De Geest
The Role of Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure Management: The Continuing Challenge of Clinical Outcome Endpoints in Heart Failure Trials. Pharmaceutics 15 (4) (2023)
Bart De Geest, Mudit Mishra
New Perspectives on Cholesterol and Lipoprotein Metabolism. International journal of molecular sciences 24 (14) (2023)
Ilayaraja Muthuramu, Mudit Mishra, Bart De Geest
Increased Remnant Lipoproteins in Apo E Deficient Mice Induce Coronary Atherosclerosis following Transverse Aortic Constriction and Aggravate the Development of Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure. Biomedicines 10 (7) (2022)
Bart De Geest, Mudit Mishra
Impact of High-Density Lipoproteins on Sepsis. International journal of molecular sciences 23 (21) (2022)
Bart De Geest, Mudit Mishra
Role of Oxidative Stress in Diabetic Cardiomyopathy. Antioxidants (Basel, Switzerland) 11 (4) (2022)
Bart De Geest, Mudit Mishra
Role of Oxidative Stress in Heart Failure: Insights from Gene Transfer Studies. Biomedicines 9 (11) (2021)
Mudit Mishra, Bart De Geest
High-Density Lipoprotein-Targeted Therapies for Heart Failure. Biomedicines 8 (12) (2020)
Joseph-Pierre Aboumsallem, Ilayaraja Muthuramu, Mudit Mishra, Bart De Geest
Cholesterol-Lowering Gene Therapy Prevents Heart Failure with Preserved Ejection Fraction in Obese Type 2 Diabetic Mice. International journal of molecular sciences 20 (9) (2019)
Joseph-Pierre Aboumsallem, Ilayaraja Muthuramu, Mudit Mishra, Herman J Kempen, Bart De Geest
Effective Treatment of Diabetic Cardiomyopathy and Heart Failure with Reconstituted HDL (Milano) in Mice. International journal of molecular sciences 20 (6) (2019)
Joseph Pierre Aboumsallem, Mudit Mishra, Ruhul Amin, Ilayaraja Muthuramu, Herman Kempen, Bart De Geest
Successful treatment of established heart failure in mice with recombinant HDL (Milano). British journal of pharmacology 175 (21) (2018)
Mudit Mishra, Ilayaraja Muthuramu, Joseph-Pierre Aboumsallem, Herman J Kempen, Bart De Geest
Reconstituted HDL (Milano) Treatment Efficaciously Reverses Heart Failure with Preserved Ejection Fraction in Mice. International journal of molecular sciences 19 (11) (2018)